Objective: To study the relationship between serum osteocalcin level and glucose and lipid metabolism in patients with type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease. Methods: The clinical ...Objective: To study the relationship between serum osteocalcin level and glucose and lipid metabolism in patients with type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease. Methods: The clinical data of 180 type 2 diabetes mellitus patients in Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China from February 2017 to January 2018 were retrospectively analyzed, including 90 cases of nonalcoholic fatty liver disease patients (group A) and 90 cases of nonalcoholic fatty liver disease-free patients (group B), meanwhile another 100 healthy subjects were selected as the control group. Then various indexes were compared between groups, including serum osteocalcin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), prothrombin activity (PTA), fasting blood glucose (FBG), glycated hemoglobin (HbA1c), triglyceride (TG), total cholesterol (TC), low density lipoprotein (LDL), high density lipoprotein (HDL), fasting insulin (FINS), fasting C peptide (FCP), HOMA insulin resistance index (HOMA-IR), HOMA β-cell function (HOMA-β). Results: The serum osteocalcin and PTA in group A were significantly lower than those in group B and the control group (P<0.05). ALT, AST, and ALP were significantly higher than those in group B and the control group (P<0.05). The FBG and HbA1c in group A were significantly higher than those in group B and the control group (P<0.05). The TG, TC, LDL, and HDL of group A and group B were significantly higher than those of the control group (P<0.05). The FINS, FCP, and HOMA-IR in group A were significantly higher than those in group B and the control group (P<0.05). HOMA-βwas significantly lower than group B and the control group (P<0.05). Pearson correlation analysis showed that the serum osteocalcin was not correlated with ALT, AST, ALP, PTA, HbA1c, TG, TC, LDL, HDL and FINS (P>0.05), but negatively correlated with FBG and HOMA-IR (P<0.05), and positively correlated with FCP and HOMA-β (P<0.05). With serum osteocalcin as the dependent variable, and ALT, AST, ALP, PTA, FBG, HbA1c, TG, TC, LDL, HDL, FINS, FCP, HOMA-IR and HOMA-β as independent variables, multiple stepwise regression analysis showed that the FBG, HOMA-IR and HOMA-β were independent risk factors for osteocalcin. Conclusions: Patients with type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease have lower serum osteocalcin level, which is susceptible to FBG, HOMA-IR, HOMA-β, and other factors.展开更多
目的探讨补肾经验方对去卵巢所致大鼠骨质疏松的防治作用。方法雌性SD大鼠40只,去卵巢复制骨质疏松病理模型,随机分为空白对照组、模型组、雌激素组和补肾经验方组。空白组与模型组均灌胃生理盐水,2 m L/d;雌激素组灌胃给予戊酸雌二醇0....目的探讨补肾经验方对去卵巢所致大鼠骨质疏松的防治作用。方法雌性SD大鼠40只,去卵巢复制骨质疏松病理模型,随机分为空白对照组、模型组、雌激素组和补肾经验方组。空白组与模型组均灌胃生理盐水,2 m L/d;雌激素组灌胃给予戊酸雌二醇0.1 mg/(kg·d);补肾经验方组灌胃给予中药复方15 g/(kg·d),给药时间持续2个月。观测补肾经验方对去卵巢所致大鼠骨强度、长骨骨骼形态学分析和血清雌二醇(E2)、骨钙素(OPG)的影响。结果雌激素和补肾经验方组大鼠骨强度、长骨骨小梁密度和血清雌二醇(E2)、骨钙素(OPG)均有不同程度的改善,与模型组比较差异有统计学意义(P<0.01)。结论补肾经验方能够改善去卵巢所致大鼠骨质疏松,其抗骨质疏松可能与增加骨钙素OPG水平有关。展开更多
文摘Objective: To study the relationship between serum osteocalcin level and glucose and lipid metabolism in patients with type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease. Methods: The clinical data of 180 type 2 diabetes mellitus patients in Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China from February 2017 to January 2018 were retrospectively analyzed, including 90 cases of nonalcoholic fatty liver disease patients (group A) and 90 cases of nonalcoholic fatty liver disease-free patients (group B), meanwhile another 100 healthy subjects were selected as the control group. Then various indexes were compared between groups, including serum osteocalcin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), prothrombin activity (PTA), fasting blood glucose (FBG), glycated hemoglobin (HbA1c), triglyceride (TG), total cholesterol (TC), low density lipoprotein (LDL), high density lipoprotein (HDL), fasting insulin (FINS), fasting C peptide (FCP), HOMA insulin resistance index (HOMA-IR), HOMA β-cell function (HOMA-β). Results: The serum osteocalcin and PTA in group A were significantly lower than those in group B and the control group (P<0.05). ALT, AST, and ALP were significantly higher than those in group B and the control group (P<0.05). The FBG and HbA1c in group A were significantly higher than those in group B and the control group (P<0.05). The TG, TC, LDL, and HDL of group A and group B were significantly higher than those of the control group (P<0.05). The FINS, FCP, and HOMA-IR in group A were significantly higher than those in group B and the control group (P<0.05). HOMA-βwas significantly lower than group B and the control group (P<0.05). Pearson correlation analysis showed that the serum osteocalcin was not correlated with ALT, AST, ALP, PTA, HbA1c, TG, TC, LDL, HDL and FINS (P>0.05), but negatively correlated with FBG and HOMA-IR (P<0.05), and positively correlated with FCP and HOMA-β (P<0.05). With serum osteocalcin as the dependent variable, and ALT, AST, ALP, PTA, FBG, HbA1c, TG, TC, LDL, HDL, FINS, FCP, HOMA-IR and HOMA-β as independent variables, multiple stepwise regression analysis showed that the FBG, HOMA-IR and HOMA-β were independent risk factors for osteocalcin. Conclusions: Patients with type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease have lower serum osteocalcin level, which is susceptible to FBG, HOMA-IR, HOMA-β, and other factors.
文摘目的探讨补肾经验方对去卵巢所致大鼠骨质疏松的防治作用。方法雌性SD大鼠40只,去卵巢复制骨质疏松病理模型,随机分为空白对照组、模型组、雌激素组和补肾经验方组。空白组与模型组均灌胃生理盐水,2 m L/d;雌激素组灌胃给予戊酸雌二醇0.1 mg/(kg·d);补肾经验方组灌胃给予中药复方15 g/(kg·d),给药时间持续2个月。观测补肾经验方对去卵巢所致大鼠骨强度、长骨骨骼形态学分析和血清雌二醇(E2)、骨钙素(OPG)的影响。结果雌激素和补肾经验方组大鼠骨强度、长骨骨小梁密度和血清雌二醇(E2)、骨钙素(OPG)均有不同程度的改善,与模型组比较差异有统计学意义(P<0.01)。结论补肾经验方能够改善去卵巢所致大鼠骨质疏松,其抗骨质疏松可能与增加骨钙素OPG水平有关。